共 480 条
[31]
Seidah NG(2020)Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection J Med Virol 75 920-929
[32]
Decroly E(2020)Personal protective equipment during the COVID-19 pandemic—a narrative review Anaesthesia 49 647-546
[33]
Kumar S(2020)From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment Zhonghua Bing Li Xue Za Zhi 55 105960-6057
[34]
Maurya VK(2020)Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection Int J Antimicrob Agents 22 221-52
[35]
Prasad AK(2020)Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 Microbes Infect 16 305-1294
[36]
Bhatt MLB(2020)Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic Nat Rev Nephrol 318 H1084-410
[37]
Saxena SK(2020)CD-sACE2 inclusion compounds: an effective treatment for corona virus disease 2019 (COVID-19) J Med Virol 181 271-318
[38]
Ceraolo C(2020)COVID-19, ACE2 and the cardiovascular consequences Am J Physiol Heart Circ Physiol 7 768-308
[39]
Giorgi FM(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell 9 761-528
[40]
Chitranshi N(2020)Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Version 2 Toxicol Rep 87 18-93